	Spese Di Vendita E Di Amministrazione		Data
Acadia Pharmaceuticals	USD 146.73M	21.82M	2025-12
Amgen	USD 1.94B	237M	2025-12
Arca Biopharma	USD 5.16M	346K	2025-03
Bayer	EUR 3.4B	140M	2025-09
Biogen	USD 545.2M	38.6M	2025-09
Brainstorm Cell Therapeutics	USD 1.78M	319K	2025-03
Bristol-Myers Squibb	USD 2.18B	392M	2025-12
Capricor Therapeutics	USD 5.88M	1.6M	2025-03
Cytokinetics	USD 91.72M	67.02M	2025-12
Eisai	JPY 111.72B	7.86B	2025-12
Eli Lilly	USD 3.13B	391.3M	2025-12
Exelixis	USD 123.02M	19.9M	2025-12
Geron	USD 41.67M	2.67M	2025-12
Halozyme Therapeutics	USD 64.64M	27.11M	2025-12
Ionis Pharmaceuticals	USD 130M	43.43M	2025-12
Ligand Pharmaceuticals	USD 28.45M	8.27M	2025-09
Merck	USD 2.85B	215M	2025-12
Novartis	USD 3.31B	134M	2025-09
Pfizer	USD 4.08B	894M	2025-12
Regeneron Pharmaceuticals	USD 775M	117.2M	2025-12
Roche Holding	CHF 7.28B	3.99B	2025-12
Sanofi	EUR 2.75B	455M	2025-12

Cytokinetics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.